A
CGEM icon

AlphaQuest’s Cullinan Oncology CGEM Stock Holding History

AlphaQuest’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,950
Closed -$300K – 385
2025
Q4 		$300K Sell
28,950
-69
-0.2% -$622 0.02% 1212
2025
Q3 		$172K Buy
29,019
+18,555
+177% +$136K 0.01% 1482
2025
Q2 		$78.8K Sell
10,464
-14,626
-58% -$118K 0.01% 1502
2025
Q1 		$190K Buy
+25,090
New +$241K 0.02% 1021
2024
Q4 		– Sell
-20,404
Closed -$342K – 1745
2024
Q3 		$342K Buy
20,404
+18,365
+901% +$326K 0.03% 841
2024
Q2 		$35.6K Sell
2,039
-6,644
-77% -$141K ﹤0.01% 1192
2024
Q1 		$148K Sell
8,683
-8,918
-51% -$138K 0.03% 739
2023
Q4 		$179K Buy
+17,601
New +$156K 0.04% 651

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

AlphaQuest's CGEM Position: Q1 2026 in Review

AlphaQuest sold out of Cullinan Oncology (CGEM) in Q1 2026, closing a stake of 28,950 shares — an estimated $300K sold.

AlphaQuest first reported a position in CGEM in Q4 2023 and held it in 8 quarters. The position peaked at $342K in Q3 2024. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • AlphaQuest reported no remaining Cullinan Oncology position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 28,950 Cullinan Oncology shares in Q1 2026, an estimated $300K.
  • AlphaQuest first reported a position in Cullinan Oncology in Q4 2023 and held it in 8 quarters.
  • AlphaQuest's Cullinan Oncology position peaked at $342K in Q3 2024.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.